Literature DB >> 3584435

The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C.

R J Clatch, R W Melvold, M C Dal Canto, S D Miller, H L Lipton.   

Abstract

Following intracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV), susceptible mouse strains develop a chronic demyelinating disease characterized histologically by mononuclear cell-rich infiltrates in the central nervous system (CNS). An immune-mediated basis for this disease is strongly supported by previous studies demonstrating a correlation between clinical disease susceptibility, the presence of particular H-2 region genotypes, and the development of chronically elevated levels of TMEV-specific, MHC class II-restricted delayed-type hypersensitivity (DTH). The present study compared disease susceptibility in (B10.S X SJL)F1 and (B10.S(26R) X SJL)F1 mice which differ only at the D region of the H-2 complex. The data conclusively demonstrates a major influence for homozygosity of H-2s alleles at the H-2D region (the murine equivalent of the human class I HLA-A, B, and C genes) in determining disease susceptibility, as measured by either clinical or histopathological endpoints. In addition, disease susceptibility strongly correlated with the development of high levels of TMEV-specific DTH in the susceptible (B10.S X SJL)F1 strain. However, disease susceptibility did not appear to correlate with TMEV titers in the CNS, TMEV-specific humoral (ELISA and neutralizing) immune responses, or virus-specific splenic T cell proliferative responses. These findings lend additional support to our hypothesis that CNS myelin damage is mediated by a TMEV-specific DTH response. The possible role of class I-restricted responses in the demyelinating process is discussed and murine TMEV-induced demyelinating disease is compared with experimental allergic encephalomyelitis as relevant animal models for human multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584435     DOI: 10.1016/0165-5728(87)90087-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.

Authors:  Michael K Axthelm; Dennis N Bourdette; Gail H Marracci; Weiping Su; Elizabeth T Mullaney; Minsha Manoharan; Steven G Kohama; Jim Pollaro; Ellen Witkowski; Paul Wang; William D Rooney; Lawrence S Sherman; Scott W Wong
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

Review 3.  Sites of antigen presentation in T-cell mediated demyelinating diseases.

Authors:  P T Massa
Journal:  Res Immunol       Date:  1989-02

4.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 5.  Cannabidiol for Viral Diseases: Hype or Hope?

Authors:  Alex Mabou Tagne; Barbara Pacchetti; Mikael Sodergren; Marco Cosentino; Franca Marino
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

Review 6.  Immunology of Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; J Kuzmak; R A Good; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

7.  Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus.

Authors:  J G Pope; C L Vanderlugt; S M Rahbe; H L Lipton; S D Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 8.  Cell-mediated immunity in virus infections of the central nervous system.

Authors:  P C Doherty
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

9.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.

Authors:  S D Miller; S J Gerety; M K Kennedy; J D Peterson; J L Trotter; V K Tuohy; C Waltenbaugh; M C Dal Canto; H L Lipton
Journal:  J Neuroimmunol       Date:  1990-01       Impact factor: 3.478

10.  Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors.

Authors:  L Fiette; C Aubert; U Müller; S Huang; M Aguet; M Brahic; J F Bureau
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.